Dsm Capital Partners LLC Abbott Laboratories Transaction History

Dsm Capital Partners LLC

$6.07 Billion
Q2 2025

A detailed history of Dsm Capital Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dsm Capital Partners LLC holds 772,348 shares of ABT stock, worth $101 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

772,348

Previous 854,111 9.57%

Holding current value

$101 Million

Previous $113 Million 7.28%

% of portfolio

1.73%

Previous 2.2%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$123.95 - $138.08 $10.1 Million - $11.3 Million	-81,763 Reduced 9.57%	772,348 $105 Million
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $588,052 - $742,184	-5,293 Reduced 0.62%	854,111 $113 Million
Q4 2024 Jan 31, 2025	BUY	$111.93 - $119.39 $41.4 Million - $44.2 Million	370,049 Added 75.62%	859,404 $97.2 Million
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $48.1 Million - $56.7 Million	480,224 Added 5259.27%	489,355 $55.8 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $57,416 - $64,090	570 Added 6.66%	9,131 $948,000
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $543,328 - $600,082	4,961 Added 137.81%	8,561 $973,000
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $324,684 - $397,440	3,600 New	3,600 $396,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $217,710 - $252,067	2,250 New	2,250 $218,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $9.58 Million - $11.3 Million	-90,530 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $2.91 Million - $3.43 Million	-26,780 Reduced 22.83%	90,530 $10.8 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $66.3 Million - $72.3 Million	-631,764 Reduced 84.34%	117,310 $12.8 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $7.76 Million - $9.43 Million	-84,701 Reduced 10.16%	749,074 $81.5 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $103 Million - $132 Million	-1,350,841 Reduced 61.83%	833,775 $76.2 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $29.5 Million - $43.2 Million	470,125 Added 27.42%	2,184,616 $172 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $3.06 Million - $3.41 Million	39,008 Added 2.33%	1,714,491 $149 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $2.07 Million - $2.24 Million	-25,237 Reduced 1.48%	1,675,483 $140 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $67.1 Million - $78.3 Million	-921,105 Reduced 35.13%	1,700,720 $143 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $30.9 Million - $37.3 Million	-466,392 Reduced 15.1%	2,621,825 $210 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $6.28 Million - $7.12 Million	-95,814 Reduced 3.01%	3,088,217 $223 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $16.9 Million - $20.4 Million	277,892 Added 9.56%	3,184,031 $234 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $25.4 Million - $28 Million	-441,285 Reduced 13.18%	2,906,139 $177 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $1.53 Million - $1.73 Million	-27,222 Reduced 0.81%	3,347,424 $201 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $4.98 Million - $5.33 Million	-92,755 Reduced 2.68%	3,374,646 $193 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $74.8 Million - $83.5 Million	1,556,566 Added 81.46%	3,467,401 $185 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,910,835	1,910,835 $92.9 Million

Others Institutions Holding ABT

# of Institutions

3,578

Shares Held

1.38B

Call Options Held

9.76M

Put Options Held

9.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsm Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dsm Capital Partners LLC with notifications on news.

Account

Dsm Capital Partners LLC Abbott Laboratories Transaction History